Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: A randomized double-blinded controlled trial
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of intralesional recombinant human epidermal growth factor in diabetic foot ulcers in Mexican patients: A randomized double-blinded controlled trial
Authors
Keywords
-
Journal
WOUND REPAIR AND REGENERATION
Volume 22, Issue 4, Pages 497-503
Publisher
Wiley
Online
2014-07-19
DOI
10.1111/wrr.12187
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Predictors of amputation in diabetics with foot ulcer: Single center experience in a large Turkish cohort
- (2014) Sena Yesil et al. Hormones-International Journal of Endocrinology and Metabolism
- Structured health care for subjects with diabetic foot ulcers results in a reduction of major amputation rates
- (2013) Matthias Weck et al. Cardiovascular Diabetology
- Economic Costs of Diabetes in the U.S. in 2012
- (2013) DIABETES CARE
- 2012 Infectious Diseases Society of America Clinical Practice Guideline for the Diagnosis and Treatment of Diabetic Foot Infections
- (2012) B. A. Lipsky et al. CLINICAL INFECTIOUS DISEASES
- Mechanisms Involved in the Development and Healing of Diabetic Foot Ulceration
- (2012) T. Dinh et al. DIABETES
- Standards of Medical Care in Diabetes--2013
- (2012) DIABETES CARE
- The Evidence for the Use of Growth Factors and Active Skin Substitutes for the Treatment of Non-Infected Diabetic Foot Ulcers (DFU): A Health Technology Assessment (HTA)
- (2011) B. Buchberger et al. EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES
- Diabetic lower extremity wounds: the rationale for growth factors-based infiltration treatment
- (2011) Jorge Berlanga-Acosta International Wound Journal
- Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers
- (2009) Astrid Langer et al. BMC HEALTH SERVICES RESEARCH
- Intralesional administration of epidermal growth factor-based formulation (Heberprot-P) in chronic diabetic foot ulcer: treatment up to complete wound closure
- (2009) José I Fernández-Montequín et al. International Wound Journal
- Intra-lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo-controlled, double-blind study
- (2009) José I Fernández-MontequÃn et al. International Wound Journal
- Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study
- (2008) M. A. Gershater et al. DIABETOLOGIA
- The pro-inflammatory environment in recalcitrant diabetic foot wounds
- (2008) Jorge Berlanga Acosta et al. International Wound Journal
- An Evidence-Based Model Comparing the Cost-effectiveness of Platelet-Rich Plasma Gel to Alternative Therapies for Patients with Nonhealing Diabetic Foot Ulcers
- (2008) Edward J. Dougherty Advances in Skin & Wound Care
- The Epidermal Growth Factor Receptor System in Skin Repair and Inflammation
- (2007) Saveria Pastore et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started